SYRS logo

Syros Pharmaceuticals (SYRS) Cash From Operations

Annual CFO

-$109.71 M
+$13.36 M+10.85%

December 31, 2023

Summary

Performance

1-Year Change

+10.85%

3-Year Change

-91.25%

5-Year Change

-172.12%

15-Year Change

-145.27%

SYRS Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

12.72%
SYRS annual cash flow from operations is higher than 12.72% of companies in Healthcare sector

High & Low

All-time High

-$11.97 M

3-Year Low

-$123.06 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
SYRS previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 27, 2025
SYRS next annual earnings announcement is scheduled for Mar 27, 2025

OtherSYRScash flowmetrics:

Annual CFI

$37.34 M
SYRS annual cash flow from investing activities is $37.34 million

Annual CFF

$43.46 M
SYRS annual cash flow from financing activities is $43.46 million

Annual FCF

-$109.98 M
SYRS annual free cash flow is -$109.98 million

Annual CAPEX

$272.00 K
SYRS annual capital expenditures is $272.00 thousand

Quarterly CFO

-$20.69 M
+$8.98 M+30.26%

September 30, 2024

Summary

Performance

3-Month Change

+30.26%

1-Year Change

+35.06%

3-Year Change

+43.93%

5-Year Change

+43.93%

SYRS Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

19.39%
SYRS quarterly cash flow from operations is higher than 19.39% of companies in Healthcare sector

High & Low

All-time High

$246.00 K
SYRS quarterly cash flow from operations is currently -8510.16% below its historical high of $246.00 thousand

3-Year Low

-$36.90 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
SYRS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 27, 2025
SYRS next earnings announcement is scheduled for Mar 27, 2025

OtherSYRScash flowmetrics:

Quarterly CFI

$0.00
SYRS quarterly cash flow from investing activities is $0.00

Quarterly CFF

$0.00
SYRS quarterly cash flow from financing activities is $0.00

Quarterly FCF

-$20.69 M
SYRS quarterly free cash flow is -$20.69 million

Quarterly CAPEX

-
SYRS quarterly capital expenditures value is unknown

TTM CFO

-$100.02 M
+$11.17 M+10.05%

September 30, 2024

Summary

Performance

3-Month Change

+10.05%

1-Year Change

+18.17%

3-Year Change

+23.03%

5-Year Change

+23.03%

SYRS TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

15.48%
SYRS TTM cash flow from operations is higher than 15.48% of companies in Healthcare sector

High & Low

All-time High

-$3.27 M

3-Year Low

-$129.95 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
SYRS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 27, 2025
SYRS next earnings announcement is scheduled for Mar 27, 2025

OtherSYRScash flowmetrics:

TTM CFI

$1.95 M
SYRS TTM cash flow from investing activities is $1.95 million

TTM CFF

$43.16 M
SYRS TTM cash flow from financing activities is $43.16 million

TTM FCF

-$100.05 M
SYRS TTM free cash flow is -$100.05 million

TTM CAPEX

-
SYRS TTM capital expenditures value is unknown

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

SYRS Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+10.8%+35.1%+18.2%
3 y3 years-91.3%+43.9%+23.0%
5 y5 years-172.1%+43.9%+23.0%

SYRS Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-10.2%+10.8%-11.5%+43.9%-0.5%+23.0%
5 y5-year-91.3%+10.8%-8510.2%+43.9%-194.1%+23.0%
alltimeall time-816.6%+10.8%-8510.2%+43.9%-2959.5%+23.0%

Syros Pharmaceuticals Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$20.69 M(-30.3%)
-$100.02 M(-10.0%)
Jun 2024
-
-$29.67 M(-4.6%)
-$111.19 M(+7.0%)
Mar 2024
-
-$31.10 M(+67.5%)
-$103.90 M(-5.3%)
Dec 2023
-$109.71 M(-10.9%)
-$18.56 M(-41.7%)
-$109.71 M(-10.2%)
Sep 2023
-
-$31.86 M(+42.3%)
-$122.23 M(-3.1%)
Jun 2023
-
-$22.39 M(-39.3%)
-$126.16 M(-2.9%)
Mar 2023
-
-$36.90 M(+18.7%)
-$129.95 M(+5.6%)
Dec 2022
-$123.06 M(+23.6%)
-$31.08 M(-13.1%)
-$123.06 M(+7.1%)
Sep 2022
-
-$35.79 M(+36.7%)
-$114.95 M(+7.1%)
Jun 2022
-
-$26.18 M(-12.8%)
-$107.29 M(-0.3%)
Mar 2022
-
-$30.02 M(+30.7%)
-$107.57 M(+8.1%)
Dec 2021
-$99.54 M(+73.5%)
-$22.97 M(-18.3%)
-$99.54 M(-6.5%)
Sep 2021
-
-$28.13 M(+6.3%)
-$106.50 M(+13.7%)
Jun 2021
-
-$26.45 M(+20.3%)
-$93.62 M(+17.6%)
Mar 2021
-
-$21.99 M(-26.5%)
-$79.60 M(+38.8%)
Dec 2020
-$57.36 M(-4.8%)
-$29.92 M(+96.2%)
-$57.36 M(+50.8%)
Sep 2020
-
-$15.26 M(+22.7%)
-$38.04 M(+11.9%)
Jun 2020
-
-$12.43 M(-5153.3%)
-$34.01 M(-14.3%)
Mar 2020
-
$246.00 K(-102.3%)
-$39.68 M(-34.1%)
Dec 2019
-$60.25 M
-$10.60 M(-5.5%)
-$60.25 M(-5.1%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$11.22 M(-38.0%)
-$63.46 M(+1.9%)
Jun 2019
-
-$18.10 M(-11.0%)
-$62.26 M(+6.9%)
Mar 2019
-
-$20.33 M(+47.2%)
-$58.24 M(+44.5%)
Dec 2018
-$40.31 M(-9.9%)
-$13.81 M(+37.8%)
-$40.31 M(+8.8%)
Sep 2018
-
-$10.03 M(-28.8%)
-$37.07 M(+1.3%)
Jun 2018
-
-$14.08 M(+486.6%)
-$36.58 M(+6.6%)
Mar 2018
-
-$2.40 M(-77.3%)
-$34.31 M(-23.3%)
Dec 2017
-$44.73 M(+10.3%)
-$10.57 M(+10.9%)
-$44.73 M(+2.2%)
Sep 2017
-
-$9.53 M(-19.3%)
-$43.76 M(+0.8%)
Jun 2017
-
-$11.81 M(-7.9%)
-$43.40 M(+1.5%)
Mar 2017
-
-$12.82 M(+33.6%)
-$42.74 M(+5.4%)
Dec 2016
-$40.54 M(+76.0%)
-$9.60 M(+4.6%)
-$40.54 M(+3.6%)
Sep 2016
-
-$9.17 M(-17.8%)
-$39.14 M(+10.5%)
Jun 2016
-
-$11.15 M(+5.0%)
-$35.43 M(+16.6%)
Mar 2016
-
-$10.62 M(+29.5%)
-$30.38 M(+31.9%)
Dec 2015
-$23.03 M(+92.4%)
-$8.20 M(+50.1%)
-$23.03 M(+55.3%)
Sep 2015
-
-$5.46 M(-10.4%)
-$14.83 M(+58.3%)
Jun 2015
-
-$6.10 M(+86.5%)
-$9.37 M(+186.5%)
Mar 2015
-
-$3.27 M
-$3.27 M
Dec 2014
-$11.97 M
-
-

FAQ

  • What is Syros Pharmaceuticals annual cash flow from operations?
  • What is the all time high annual CFO for Syros Pharmaceuticals?
  • What is Syros Pharmaceuticals annual CFO year-on-year change?
  • What is Syros Pharmaceuticals quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Syros Pharmaceuticals?
  • What is Syros Pharmaceuticals quarterly CFO year-on-year change?
  • What is Syros Pharmaceuticals TTM cash flow from operations?
  • What is the all time high TTM CFO for Syros Pharmaceuticals?
  • What is Syros Pharmaceuticals TTM CFO year-on-year change?

What is Syros Pharmaceuticals annual cash flow from operations?

The current annual CFO of SYRS is -$109.71 M

What is the all time high annual CFO for Syros Pharmaceuticals?

Syros Pharmaceuticals all-time high annual cash flow from operations is -$11.97 M

What is Syros Pharmaceuticals annual CFO year-on-year change?

Over the past year, SYRS annual cash flow from operations has changed by +$13.36 M (+10.85%)

What is Syros Pharmaceuticals quarterly cash flow from operations?

The current quarterly CFO of SYRS is -$20.69 M

What is the all time high quarterly CFO for Syros Pharmaceuticals?

Syros Pharmaceuticals all-time high quarterly cash flow from operations is $246.00 K

What is Syros Pharmaceuticals quarterly CFO year-on-year change?

Over the past year, SYRS quarterly cash flow from operations has changed by +$11.17 M (+35.06%)

What is Syros Pharmaceuticals TTM cash flow from operations?

The current TTM CFO of SYRS is -$100.02 M

What is the all time high TTM CFO for Syros Pharmaceuticals?

Syros Pharmaceuticals all-time high TTM cash flow from operations is -$3.27 M

What is Syros Pharmaceuticals TTM CFO year-on-year change?

Over the past year, SYRS TTM cash flow from operations has changed by +$22.21 M (+18.17%)